Targeted HD-tDCS to Improve Upper Limb Rehabilitation in SCI

Running, not enrolling · Not applicable

Conditions studied: Spinal Cord Injuries, Spinal Cord Diseases

In brief

The proposed project seeks to maximize the functional recovery achieved during the rehabilitation of the paretic upper limbs in individuals with SCI. The investigation will work towards optimizing the use of transcranial direct current stimulation (tDCS), an adjunct known to improve the effectiveness of rehabilitation. In particular, the relationship between the specificity of current delivery and functional benefit will be explored, and findings may lead to a framework that can be translated to the clinic setting.

Key facts

Study ID

NCT05589415

Run by

University of Texas Rio Grande Valley

People needed

24

Starts

2020-11-23

Expected to finish

2027-05-23

Last updated by the study team

2026-07-24

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Provision of signed and dated informed consent form
• Stated willingness to comply with all study procedures and availability for the duration of the study
• Age between 18 and 75 years
• Physician diagnosed cervical incomplete spinal cord injury or lesion (iSCI)
• Classified by the American Spinal Cord Association (AIS) impairment scale as AIS C or D
• iSCI occurred at least 18 months ago
• Level of injury or lesion is between C2 and T1
• Bicep strength must be classified as ≥ 3 muscle grade as defined by the medical research council (MRC) scale
• Tricep strength must be at least an MRC grade of 2 and be at least 1 muscle grade lower than bicep
• Both the biceps and triceps will be required to elicit an active motor evoked potential >200 uV with transcranial magnetic stimulation
• Must maintain current medication regime
• Must present with a weaker side of the body, as indicated by a Upper Extremity Motor Score (UEMS) score difference between the left and right side
• UEMS < 40 (50 max score)

You may not qualify if…

• Pacemaker or other implanted device
• Metal in the skull
• History of seizures
• Pregnancy
• First-degree relative with medication-resistant epilepsy
• Current participation in upper limb rehabilitation therapies
• Current use of illicit drugs, abusing alcohol, or have withdrawn from alcohol in the last 6 months
• Other neurological impairment or condition
• Pressure ulcers
• Significant lower motor neuron loss at C7 as noted by a nerve conduction velocity <50 m/s
• History of traumatic brain injury, as documented by Rancho Scale Impairment of ≤ 5
• History of brain MRI documented focal cerebral cortex infarct (e.g. hydrocephalus)
• Contractures at the elbow
• Severe spasticity as noted by a Modified Ashworth Scale (MAS) > 4.
• Documented, non-sedated post-traumatic amnesia lasting more than 48 hours
• Demonstrated present gains in motor recovery as noted by a >10% change in triceps strength from pre-test #1 to pre-test #2
• A neuroactive medication that has the potential to lower the seizure threshold

Where it is running

• University of Texas Rio Grande Valley — Harlingen, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.